Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine
Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 14 individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197) . It is contained in the vaccine under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F for intramuscular injection. The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
| Trade Name | Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine |
| Generic | Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen |
| Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen Other Names | Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine |
| Type | |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine
